1
|
Stupp R, Mason WP, van den Bent MJ, Weller
M, Fisher B, Taphoorn MJ, Belanger K, Brandes AA, Marosi C, Bogdahn
U, et al European Organisation for Research and Treatment of Cancer
Brain Tumor and Radiotherapy Groups; National Cancer Institute of
Canada Clinical Trials Group: Radiotherapy plus concomitant and
adjuvant temozolomide for glioblastoma. N Engl J Med. 352:987–996.
2005. View Article : Google Scholar : PubMed/NCBI
|
2
|
Taylor LP: Diagnosis, treatment, and
prognosis of glioma: Five new things. Neurology. 75(Suppl 1):
S28–S32. 2010. View Article : Google Scholar : PubMed/NCBI
|
3
|
Nagano N, Sasaki H, Aoyagi M and Hirakawa
K: Invasion of experimental rat brain tumor: Early morphological
changes following microinjection of C6 glioma cells. Acta
Neuropathol. 86:117–125. 1993. View Article : Google Scholar : PubMed/NCBI
|
4
|
Vajkoczy P, Farhadi M, Gaumann A,
Heidenreich R, Erber R, Wunder A, Tonn JC, Menger MD and Breier G:
Microtumor growth initiates angiogenic sprouting with simultaneous
expression of VEGF, VEGF receptor-2, and angiopoietin-2. J Clin
Invest. 109:777–785. 2002. View Article : Google Scholar : PubMed/NCBI
|
5
|
Karmakar S, Olive MF, Banik NL and Ray SK:
Intracranial stereotaxic cannulation for development of orthotopic
glioblastoma allograft in Sprague-Dawley rats and
histoimmunopathological characterization of the brain tumor.
Neurochem Res. 32:2235–2242. 2007. View Article : Google Scholar : PubMed/NCBI
|
6
|
Vince GH, Bendszus M, Schweitzer T,
Goldbrunner RH, Hildebrandt S, Tilgner J, Klein R, Solymosi L,
Christian Tonn J and Roosen K: Spontaneous regression of
experimental gliomas - an immunohistochemical and MRI study of the
C6 glioma spheroid implantation model. Exp Neurol. 190:478–485.
2004. View Article : Google Scholar : PubMed/NCBI
|
7
|
Sibenaller ZA, Etame AB, Ali MM, Barua M,
Braun TA, Casavant TL and Ryken TC: Genetic characterization of
commonly used glioma cell lines in the rat animal model system.
Neurosurg Focus. 19:E12005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Bernstein JJ, Laws ER Jr, Levine KV, Wood
LR, Tadvalkar G and Goldberg WJ: C6 glioma-astrocytoma cell and
fetal astrocyte migration into artificial basement membrane: A
permissive substrate for neural tumors but not fetal astrocytes.
Neurosurgery. 28:652–658. 1991. View Article : Google Scholar : PubMed/NCBI
|
9
|
Pedersen PH, Marienhagen K, Mørk S and
Bjerkvig R: Migratory pattern of fetal rat brain cells and human
glioma cells in the adult rat brain. Cancer Res. 53:5158–5165.
1993.PubMed/NCBI
|
10
|
Carbonell WS, Ansorge O, Sibson N and
Muschel R: The vascular basement membrane as 'soil' in brain
metastasis. PLoS One. 4:e58572009. View Article : Google Scholar
|
11
|
Kienast Y, von Baumgarten L, Fuhrmann M,
Klinkert WE, Goldbrunner R, Herms J and Winkler F: Real-time
imaging reveals the single steps of brain metastasis formation. Nat
Med. 16:116–122. 2010. View
Article : Google Scholar
|
12
|
Holash J, Maisonpierre PC, Compton D,
Boland P, Alexander CR, Zagzag D, Yancopoulos GD and Wiegand SJ:
Vessel cooption, regression, and growth in tumors mediated by
angiopoietins and VEGF. Science. 284:1994–1998. 1999. View Article : Google Scholar : PubMed/NCBI
|
13
|
Winkler F, Kienast Y, Fuhrmann M, Von
Baumgarten L, Burgold S, Mitteregger G, Kretzschmar H and Herms J:
Imaging glioma cell invasion in vivo reveals mechanisms of
dissemination and peritumoral angiogenesis. Glia. 57:1306–1315.
2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Farin A, Suzuki SO, Weiker M, Goldman JE,
Bruce JN and Canoll P: Transplanted glioma cells migrate and
proliferate on host brain vasculature: A dynamic analysis. Glia.
53:799–808. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Giese A, Bjerkvig R, Berens ME and
Westphal M: Cost of migration: Invasion of malignant gliomas and
implications for treatment. J Clin Oncol. 21:1624–1636. 2003.
View Article : Google Scholar : PubMed/NCBI
|
16
|
Mariani L, Beaudry C, McDonough WS,
Hoelzinger DB, Kaczmarek E, Ponce F, Coons SW, Giese A, Seiler RW
and Berens ME: Death-associated protein 3 (Dap-3) is overexpressed
in invasive glioblastoma cells in vivo and in glioma cell lines
with induced motility phenotype in vitro. Clin Cancer Res.
7:2480–2489. 2001.PubMed/NCBI
|
17
|
Giese A, Loo MA, Tran N, Haskett D, Coons
SW and Berens ME: Dichotomy of astrocytoma migration and
proliferation. Int J Cancer. 67:275–282. 1996. View Article : Google Scholar : PubMed/NCBI
|
18
|
Saito R, Bringas J, Mirek H, Berger MS and
Bankiewicz KS: Invasive phenotype observed in
1,3-bis(2-chloroethyl)-1-nitrosourea-resistant sublines of 9L rat
glioma cells: A tumor model mimicking a recurrent malignant glioma.
J Neurosurg. 101:826–831. 2004. View Article : Google Scholar : PubMed/NCBI
|
19
|
Chicoine MR and Silbergeld DL: Invading C6
glioma cells maintaining tumorigenicity. J Neurosurg. 83:665–671.
1995. View Article : Google Scholar : PubMed/NCBI
|
20
|
Hassaneen W, Levine NB, Suki D, Salaskar
AL, de Moura Lima A, McCutcheon IE, Prabhu SS, Lang FF, DeMonte F,
Rao G, et al: Multiple craniotomies in the management of multifocal
and multicentric glioblastoma. Clinical article. J Neurosurg.
114:576–584. 2011. View Article : Google Scholar
|
21
|
Grobben B, De Deyn PP and Slegers H: Rat
C6 glioma as experimental model system for the study of
glioblastoma growth and invasion. Cell Tissue Res. 310:257–270.
2002. View Article : Google Scholar : PubMed/NCBI
|
22
|
Wang TC, Hsiao IT, Cheng YK, Wey SP, Yen
TC and Lin KJ: Noninvasive monitoring of tumor growth in a rat
glioma model: Comparison between neurological assessment and animal
imaging. J Neurooncol. 104:669–678. 2011. View Article : Google Scholar : PubMed/NCBI
|
23
|
Mikheeva SA, Mikheev AM, Petit A, Beyer R,
Oxford RG, Khorasani L, Maxwell JP, Glackin CA, Wakimoto H,
González-Herrero I, et al: TWIST1 promotes invasion through
mesenchymal change in human glioblastoma. Mol Cancer. 9(194)2010.
View Article : Google Scholar : PubMed/NCBI
|
24
|
Walsh EM, Kim R, Del Valle L, Weaver M,
Sheffield J, Lazarovici P and Marcinkiewicz C: Importance of
interaction between nerve growth factor and α9β1 integrin in glial
tumor angiogenesis. Neuro-oncol. 14:890–901. 2012. View Article : Google Scholar
|
25
|
Assimakopoulou M, Kondyli M, Gatzounis G,
Maraziotis T and Varakis J: Neurotrophin receptors expression and
JNK pathway activation in human astrocytomas. BMC Cancer.
7(202)2007. View Article : Google Scholar : PubMed/NCBI
|
26
|
Brat DJ and Van Meir EG: Vaso-occlusive
and prothrombotic mechanisms associated with tumor hypoxia,
necrosis, and accelerated growth in glioblastoma. Lab Invest.
84:397–405. 2004. View Article : Google Scholar : PubMed/NCBI
|
27
|
McCaslin AF, Chen BR, Radosevich AJ, Cauli
B and Hillman EM: In vivo 3D morphology of astrocyte-vasculature
interactions in the somatosensory cortex: Implications for
neurovascular coupling. J Cereb Blood Flow Metab. 31:795–806. 2011.
View Article : Google Scholar :
|
28
|
Seylaz J, Charbonné R, Nanri K, Von Euw D,
Borredon J, Kacem K, Méric P and Pinard E: Dynamic in vivo
measurement of erythrocyte velocity and flow in capillaries and of
microvessel diameter in the rat brain by confocal laser microscopy.
J Cereb Blood Flow Metab. 19:863–870. 1999. View Article : Google Scholar : PubMed/NCBI
|
29
|
Johnston AL, Lun X, Rahn JJ, Liacini A,
Wang L, Hamilton MG, Parney IF, Hempstead BL, Robbins SM, Forsyth
PA, et al: The p75 neurotrophin receptor is a central regulator of
glioma invasion. PLoS Biol. 5:e2122007. View Article : Google Scholar : PubMed/NCBI
|
30
|
Jacobs VL, Valdes PA, Hickey WF and De Leo
JA: Current review of in vivo GBM rodent models: Emphasis on the
CNS-1 tumour model. ASN Neuro. 3:e000632011. View Article : Google Scholar : PubMed/NCBI
|
31
|
Gorin F, Harley W, Schnier J, Lyeth B and
Jue T: Perinecrotic glioma proliferation and metabolic profile
within an intrace-rebral tumor xenograft. Acta Neuropathol.
107:235–244. 2004. View Article : Google Scholar : PubMed/NCBI
|
32
|
Hoelzinger DB, Mariani L, Weis J, Woyke T,
Berens TJ, McDonough WS, Sloan A, Coons SW and Berens ME: Gene
expression profile of glioblastoma multiforme invasive phenotype
points to new therapeutic targets. Neoplasia. 7:7–16. 2005.
View Article : Google Scholar : PubMed/NCBI
|
33
|
Zagzag D, Lukyanov Y, Lan L, Ali MA,
Esencay M, Mendez O, Yee H, Voura EB and Newcomb EW:
Hypoxia-inducible factor 1 and VEGF upregulate CXCR4 in
glioblastoma: Implications for angiogenesis and glioma cell
invasion. Lab Invest. 86:1221–1232. 2006. View Article : Google Scholar : PubMed/NCBI
|
34
|
Zhao Y, Xiao A, diPierro CG, Carpenter JE,
Abdel-Fattah R, Redpath GT, Lopes MB and Hussaini IM: An extensive
invasive intracranial human glioblastoma xenograft model: Role of
high level matrix metalloproteinase 9. Am J Pathol. 176:3032–3049.
2010. View Article : Google Scholar : PubMed/NCBI
|
35
|
Rubenstein JL, Kim J, Ozawa T, Zhang M,
Westphal M, Deen DF and Shuman MA: Anti-VEGF antibody treatment of
glioblastoma prolongs survival but results in increased vascular
cooption. Neoplasia. 2:306–314. 2000. View Article : Google Scholar : PubMed/NCBI
|
36
|
Keunen O, Johansson M, Oudin A, Sanzey M,
Rahim SA, Fack F, Thorsen F, Taxt T, Bartos M, Jirik R, et al:
Anti-VEGF treatment reduces blood supply and increases tumor cell
invasion in glioblastoma. Proc Natl Acad Sci USA. 108:3749–3754.
2011. View Article : Google Scholar : PubMed/NCBI
|
37
|
Fidler IJ: The pathogenesis of cancer
metastasis: The 'seed and soil' hypothesis revisited. Nat Rev
Cancer. 3:453–458. 2003. View Article : Google Scholar : PubMed/NCBI
|
38
|
Fidler IJ and Poste G: The 'seed and soil'
hypothesis revisited. Lancet Oncol. 9(808)2008. View Article : Google Scholar
|